Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ola Nilsson

Showing results (1-10 of 182) with videos related to

Pageof 19
Sort By:
European Journal of Endocrinology|May 16, 2020
Aggrecanopathies highlight the need for genetic evaluation of ISS childrenOla Nilsson
Lakartidningen|March 1, 2021
[New treatments for achondroplasia may be efficacious in other forms of short stature]Ola Nilsson
Neuroendocrinology|September 19, 2012
Profiling of ileal carcinoidsOla Nilsson
Pediatric Nephrology (Berlin, Germany)|February 22, 2005
Impact of growth plate senescence on catch-up growth and epiphyseal fusionOla Nilsson, Jeffrey Baron
Hormone Research in Paediatrics|May 18, 2025
Persistent hyperparathyroidism in vitamin D-dependent rickets type 2A does not prevent normalization of hypophosphatemia or healing of the ricketsMaria Lodefalk, Ola Nilsson
Trends in Endocrinology and Metabolism: TEM|September 24, 2004
Fundamental limits on longitudinal bone growth: growth plate senescence and epiphyseal fusionOla Nilsson, Jeffrey Baron
Frontiers in Endocrinology|December 7, 2020
Discordance Between Stimulated and Spontaneous Growth Hormone Levels in Short Children Is Dependent on Cut-Off Level and Partly Explained by RefractorinessOtto Lennartsson, Ola Nilsson, Maria Lodefalk
Hormone Research in Paediatrics|June 10, 2025
Priming short children with sex steroids prior to growth hormone testing decreases the frequency of divergent resultsOtto Lennartsson, Ola Nilsson, Maria Lodefalk
BMC Musculoskeletal Disorders|May 1, 2020
Reconstruction of finger joints using autologous rib perichondrium - an observational study at a single Centre with a median follow-up of 37 yearsDaniel Muder, Ola Nilsson, Torbjörn Vedung
Expert Opinion on Investigational Drugs|April 2, 2009
Treatment of gastrointestinal stromal tumours: imatinib, sunitinib -- and then?Bengt Nilsson, Ola Nilsson, Håkan Ahlman
Pageof 19

Showing results (1-10 of 182) with videos related to

Sort By:
Pageof 19
European Journal of Endocrinology|May 16, 2020
Aggrecanopathies highlight the need for genetic evaluation of ISS childrenOla Nilsson
Lakartidningen|March 1, 2021
[New treatments for achondroplasia may be efficacious in other forms of short stature]Ola Nilsson
Neuroendocrinology|September 19, 2012
Profiling of ileal carcinoidsOla Nilsson
Pediatric Nephrology (Berlin, Germany)|February 22, 2005
Impact of growth plate senescence on catch-up growth and epiphyseal fusionOla Nilsson, Jeffrey Baron
Hormone Research in Paediatrics|May 18, 2025
Persistent hyperparathyroidism in vitamin D-dependent rickets type 2A does not prevent normalization of hypophosphatemia or healing of the ricketsMaria Lodefalk, Ola Nilsson
Trends in Endocrinology and Metabolism: TEM|September 24, 2004
Fundamental limits on longitudinal bone growth: growth plate senescence and epiphyseal fusionOla Nilsson, Jeffrey Baron
Frontiers in Endocrinology|December 7, 2020
Discordance Between Stimulated and Spontaneous Growth Hormone Levels in Short Children Is Dependent on Cut-Off Level and Partly Explained by RefractorinessOtto Lennartsson, Ola Nilsson, Maria Lodefalk
Hormone Research in Paediatrics|June 10, 2025
Priming short children with sex steroids prior to growth hormone testing decreases the frequency of divergent resultsOtto Lennartsson, Ola Nilsson, Maria Lodefalk
BMC Musculoskeletal Disorders|May 1, 2020
Reconstruction of finger joints using autologous rib perichondrium - an observational study at a single Centre with a median follow-up of 37 yearsDaniel Muder, Ola Nilsson, Torbjörn Vedung
Expert Opinion on Investigational Drugs|April 2, 2009
Treatment of gastrointestinal stromal tumours: imatinib, sunitinib -- and then?Bengt Nilsson, Ola Nilsson, Håkan Ahlman
Pageof 19